Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Apyx Medical Inc

APYX
Current price
1.43 USD +0.03 USD (+2.14%)
Last closed 1.48 USD
ISIN US03837C1062
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 63 241 752 USD
Yield for 12 month -47.23 %
1Y
3Y
5Y
10Y
15Y
APYX
21.11.2021 - 28.11.2021

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Address: 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.83 USD

P/E ratio

Dividend Yield

Current Year

+52 349 000 USD

Last Year

+44 510 000 USD

Current Quarter

+11 487 000 USD

Last Quarter

+12 149 000 USD

Current Year

+33 759 000 USD

Last Year

+29 131 000 USD

Current Quarter

+6 954 000 USD

Last Quarter

+2 811 000 USD

Key Figures APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -21 674 000 USD
Operating Margin TTM -45.66 %
PE Ratio
Return On Assets TTM -21.83 %
PEG Ratio
Return On Equity TTM -110.25 %
Wall Street Target Price 2.83 USD
Revenue TTM 49 031 000 USD
Book Value 0.77 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -10.50 %
Dividend Yield
Gross Profit TTM 29 131 000 USD
Earnings per share -0.82 USD
Diluted Eps TTM -0.82 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -57.86 %

Dividend Analytics APYX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.53
Price Sales TTM 1.29
Enterprise Value EBITDA -5.33
Price Book MRQ 5.73

Financials APYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators APYX

For 52 weeks

0.97 USD 2.80 USD
50 Day MA 1.36 USD
Shares Short Prior Month 140 478
200 Day MA 1.40 USD
Short Ratio 5.49
Shares Short 119 969
Short Percent 0.73 %